Premium
Community‐acquired methicillin‐resistant Staphylococcus aureus in nasal vestibular abscess
Author(s) -
Earley Marisa A.,
Friedel Mark E.,
Govindaraj Satish,
Tessema Belachew,
Eloy Jean Anderson
Publication year - 2011
Publication title -
international forum of allergy and rhinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.503
H-Index - 46
eISSN - 2042-6984
pISSN - 2042-6976
DOI - 10.1002/alr.20061
Subject(s) - medicine , staphylococcus aureus , clindamycin , abscess , methicillin resistant staphylococcus aureus , erythromycin , antibiotics , surgery , microbiology and biotechnology , bacteria , genetics , biology
Background Community‐acquired methicillin‐resistant Staphylococcus aureus (MRSA) is a recognized entity that is increasingly responsible for skin and soft tissue infections. However, it is not the usual pathogen isolated in nasal vestibular abscess. Methods We present a series of 13 consecutive patients presenting to a tertiary care center with nasal vestibular abscess over a 2.5‐year period. Results All abscesses were cultured and 100% (13/13) grew S. aureus . Of the S. aureus isolates, 92% (12/13) were MRSA. Antibiotic susceptibilities of the MRSA isolates were as follows: 100% were susceptible to rifampin, trimethoprim‐sulfamethoxazole, and tetracycline, 75% to clindamycin, 58% to fluoroquinolones, and 17% to erythromycin. Conclusion MRSA is an important pathogen in the community. It is therefore critical to appreciate its potential predominance in nasal vestibular abscess. Clinicians should obtain cultures, modify antibiotic therapy as warranted, and initiate empiric therapy to include MRSA coverage for nasal vestibular abscess. © 2011 ARS‐AAOA, LLC.